Seres Therapeutics
MCRB
MCRB
76 hedge funds and large institutions have $820M invested in Seres Therapeutics in 2016 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 36 increasing their positions, 13 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
20% less capital invested
Capital invested by funds: $1.03B → $820M (-$208M)
39% less call options, than puts
Call options by funds: $931K | Put options by funds: $1.52M
Holders
76
Holding in Top 10
2
Calls
$931K
Puts
$1.52M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$9.12M | |
| 3 | +$8.76M | |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$8.22M |
| 5 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$3.17M |
Top Sellers
| 1 | -$4.41M | |
| 2 | -$2.91M | |
| 3 | -$507K | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$287K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
-$231K |